Lastly, we monitored the expression of GPX1, GPX4, and SELENOP genes in patients with ovarian cancer using the publicly available Oncomine database to elucidate the clinical significance of GPx4 in ovarian cancer. This evidence concerns the gene GPX1 and ovarian carcinoma.